title: Acceptability of misoprostol-only medical termination of pregnancy compared with vacuum aspiration: an international, multicentre trial.
abstract: OBJECTIVE
  To compare women's acceptance of misoprostol-only medical termination of pregnancy (TOP) with surgical TOP.
  
  
  METHODS
  Prospective cohort study.
  
  
  METHODS
  Termination of pregnancy clinics in New Delhi, Mumbai, Hanoi, Tbilisi, Trivandrum and Yerevan.
  
  
  METHODS
  Women requesting TOP, at 63 days of gestation or less, at study sites where both medical and surgical methods were available.
  
  
  METHODS
  Serial surveys eliciting measures of women's satisfaction and acceptance of TOP method were administered. Data were analysed using cross-tabulation and logistic regression to determine if TOP method was predictive of acceptability.
  
  
  METHODS
  Patient acceptance.
  
  
  RESULTS
  High acceptability of both surgical and misoprostol-only TOP.
  
  
  CONCLUSIONS
  Where medical TOP with mifepristone is not available, misoprostol-only medical TOP is acceptable to women who have the choice between medical or surgical techniques.
authors.affiliation: Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland. rodriguezmar@who.int
authors.forename: M I
authors.initials: MI
authors.lastname: Rodriguez
authors.forename: A
authors.initials: A
authors.lastname: Seuc
authors.forename: N
authors.initials: N
authors.lastname: Kapp
authors.forename: H
authors.initials: H
authors.lastname: von Hertzen
authors.forename: N T M
authors.initials: NT
authors.lastname: Huong
authors.forename: D
authors.initials: D
authors.lastname: Wojdyla
authors.forename: S
authors.initials: S
authors.lastname: Mittal
authors.forename: K
authors.initials: K
authors.lastname: Arustamyan
authors.forename: R
authors.initials: R
authors.lastname: Shah
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage; D000028:Abortion, Induced / Q000379:methods*; D000328:Adult; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016015:Logistic Models; D016595:Misoprostol / Q000008:administration & dosage; D057240:Patient Preference / Q000706:statistics & numerical data; D017060:Patient Satisfaction / Q000706:statistics & numerical data*; D011247:Pregnancy; D011446:Prospective Studies; D014619:Vacuum Curettage
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol